Tudor Investment Corp
CNTA

Tudor Investment Corp’s Centessa Pharmaceuticals CNTA Stock Holding History

Tudor Investment Corp’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-121,810
Closed -$3.05M – 3712
2025
Q4 		$3.05M Buy
121,810
+64,000
+111% +$1.62M 0.01% 1498
2025
Q3 		$1.4M Buy
57,810
+6,959
+14% +$124K ﹤0.01% 2037
2025
Q2 		$668K Sell
50,851
-55,074
-52% -$698K ﹤0.01% 2398
2025
Q1 		$1.52M Buy
+105,925
New +$1.73M 0.01% 1529
2021
Q3 		– Sell
-43,079
Closed -$957K – 2495
2021
Q2 		$957K Buy
+43,079
New +$1.01M 0.02% 889

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Tudor Investment Corp's CNTA Position: Q1 2026 in Review

Tudor Investment Corp sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 121,810 shares — an estimated $3.05M sold.

Tudor Investment Corp first reported a position in CNTA in Q2 2021 and held it in 5 quarters. The position peaked at $3.05M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Tudor Investment Corp reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 121,810 Centessa Pharmaceuticals shares in Q1 2026, an estimated $3.05M.
  • Tudor Investment Corp first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Tudor Investment Corp's Centessa Pharmaceuticals position peaked at $3.05M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.